Fig. 1 · Structure
Documents & Downloads
Myristyl nicotinate
Nicotinic Acid Derivative
Myristyl nicotinate is a lipophilic derivative of nicotinic acid, acting as an ester proagent. It facilitates the transdermal delivery of nicotinic acid, targeted toward preventing actinic keratosis and its advancement to skin cancer. Additionally, myristyl nicotinate has demonstrated the ability to enhance epidermal differentiation in photodamaged skin, thereby increasing NAD content and reinforcing the skin barrier.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 273203-62-6 |
| Applications | Nicotinic Acid Derivative |
| Formula | C20H33NO2 |
| Molecular Weight | 319.48 |
| Synonyms | Tetradecyl nicotinate |
| SMILES | O=C(C1=CC=CN=C1)OCCCCCCCCCCCCCC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.